Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Trial Begins Testing Sickle Cell Blood Therapy

Red blood cells with sickle cell disease (NCATS.NIH.gov)

23 June 2015. A clinical trial began enrolling participants testing a synthesized therapy for sickle cell disease to improve the flow of blood cells blocked by the condition and relieve the intense pain that results. The late-stage trial is being conducted by drug maker Pfizer . . . → Read More: Trial Begins Testing Sickle Cell Blood Therapy

Smart Insulin Patch Designed to Regulate Blood Glucose

Smart insulin skin patch (Zhen Gu Lab, Univ. of North Carolina, Chapel Hill)

23 June 2015. A skin patch made with tiny needles can dispense insulin and regulate blood glucose levels in lab mice for up to 9 hours. The device is being developed by a joint biomedical engineering department at University of . . . → Read More: Smart Insulin Patch Designed to Regulate Blood Glucose

Study Urges Better Heart Implant Device Tracking

(PublicDomainPictures, Pixabay)

22 June 2015. Current methods of monitoring implanted heart devices, conclude researchers at University of California in San Francisco, may not be adequate for spotting the number of problems with the devices leading to patients’ deaths. The findings of the team led by UCSF cardiologist Zian Tseng were reported today in . . . → Read More: Study Urges Better Heart Implant Device Tracking

Allied-Bristol Licenses Chinese Root Extract Technology

Malcolm Whitman and Tracy Keller, left and center, with co-author and radiologist Ralph Mazitschek after 2012 publication on halofuginone (Angela Alberti, Harvard Medical School)

22 June 2015. A joint venture of drug maker Bristol-Myers Squibb and science commercialization company Allied Minds is licensing research at Harvard University on the actions of a Chinese . . . → Read More: Allied-Bristol Licenses Chinese Root Extract Technology

$50,000 Challenge Seeks Liver Disease Biomarkers

(Mikael Häggström, Wikimedia Commons)

19 June 2015. A new challenge on InnoCentive asks for biomarkers indicating damage to the liver, conditions that today often require invasive procedures such as biopsies to diagnose. The competition has a total purse of $50,000 and a deadline for proposals of 17 August 2015.

InnoCentive in Waltham, Massachusetts . . . → Read More: $50,000 Challenge Seeks Liver Disease Biomarkers

Internet-of-Things Security Architecture Designed

(ClkerFreeVectorImages, Pixabay)

19 June 2015. Engineering students at Ruhr-Universität Bochum in Germany are developing a security architecture to protect wireless communications among small household devices connected in what’s known as the Internet-of-Things. The team from the university’s Horst Görtz Institute that specializes in IT security is also receiving funds from a German government . . . → Read More: Internet-of-Things Security Architecture Designed

Trial Testing Precision Medicine as Skin Cancer Therapy

(Arun Kulshreshtha, Wikimedia Commons)

18 June 2015. A clinical trial is recruiting participants to test targeted molecular therapies as treatments for advanced cases of skin cancer. The study plans to enroll 96 individuals with melanoma, an advanced and dangerous form of skin cancer, found spreading to other organs in the body and cannot . . . → Read More: Trial Testing Precision Medicine as Skin Cancer Therapy

Anti-Infection Compound Devised for Dental, Wound Care

Michele Barbour (Bhagesh Sachania, University of Bristol)

18 June 2015. A new formulation of a common antibacterial agent can protect against infections for weeks or months at a time, according to its developers at University of Bristol in the U.K. The team led by Bristol dental materials scientist Michele Barbour is developing Pertinax, . . . → Read More: Anti-Infection Compound Devised for Dental, Wound Care

Drug Makers Start Prostate Cancer Patient Registry

Micrograph of prostatic acinar adenocarcinoma, the most common form of prostate cancer (Nephron, Wikimedia Commons)

17 June 2015. Two companies that developed a drug to treat prostate cancer, began enrolling individuals into a registry of people with prostate cancer to track their quality of care. Astellas U.S., a division of Astellas Pharma in . . . → Read More: Drug Makers Start Prostate Cancer Patient Registry

Institute Developing Engineered Bacteria for Gut Diseases

E. coli bacteria (National Institute of Allergy and Infectious Diseases)

17 June 2015. Engineers and medical researchers at Harvard University are designing genetically engineered bacteria that can diagnose and treat gastrointestinal disorders affecting travelers, as well as people suffering from acute or chronic gut diseases. The team from Wyss Institute for Biologically Inspired . . . → Read More: Institute Developing Engineered Bacteria for Gut Diseases